Rep. Debbie Wasserman Schultz has disclosed 8 buys and 8 sales since Dec 2023
House · D-FL
Committees: Appropriations, Foreign Affairs
Rep. Debbie Wasserman Schultz's record
3 months after each buy, from the first price a copier could get.
6 buys since 2024 with 3 months of prices.
Bought most often
Every disclosure
Newest first. Members report amounts as ranges.
Ichor Holdings Ltd
Dril-Quip Inc
AngioDynamics Inc
Berry Corp
Stratasys Ltd
Ichor Holdings Ltd
ViaSat Inc
AngioDynamics Inc
AngioDynamics Inc
New Gold Inc
ViaSat Inc
Patterson-UTI Energy Inc
New Gold Inc
Baxter International Inc
Hecla Mining Co
First Trust MLP and Energy Income Fund
About Debbie Wasserman Schultz
Debbie Wasserman Schultz is a Democratic U.S. Representative for Florida's 25th Congressional District, serving since 2005 after prior roles in the Florida House (1992-2000) and Senate (2000-2004).( Born in 1966 on Long Island, New York, she earned a B.A. and M.A. in political science from the University of Florida and became Florida's first Jewish congresswoman, advancing through leadership positions like Chair of the Democratic National Committee (2011-2016) and Chief Deputy Whip.(
Currently Ranking Member on the House Appropriations Committee, she previously chaired the Military Construction and Veterans Affairs Subcommittee and serves on Agriculture and Energy and Water subcommittees, advocating for Everglades protection, veterans, and health care access.( Notable legislation includes the PROTECT Our Children Act, Virginia Graeme Baker Pool and Spa Safety Act, EARLY Act (breast cancer awareness, enacted via Affordable Care Act), and PALS Act for mammograms.( Recent stock trades by her office in DRQ, ANGO, BRY, SSYS, and ICHR fall under STOCK Act disclosure requirements, with no specific public scrutiny detailed in available records, though congressional trading draws ongoing attention for potential conflicts.(
Written by Perplexity from public sources.
Disclosures come from STOCK Act filings. Returns start at the first open after a buy was disclosed. Not investment advice.